Autoimmune cell therapy and T-cell engager trial starts by region

3 regions, 2020 to 2025

112 Global, 2025

Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, China, United States. 18 observations from 2020 to 2025, ranging from 0 to 112. Latest values: Global 112 (2025); China 76 (2025); United States 21 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global China United States
Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, China, United States. 18 observations from 2020 to 2025, ranging from 0 to 112. Latest values: Global 112 (2025); China 76 (2025); United States 21 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global China United States
Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, China, United States. 18 observations from 2020 to 2025, ranging from 0 to 112. Latest values: Global 112 (2025); China 76 (2025); United States 21 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global China United States
View the underlying data
Autoimmune cell therapy and T-cell engager trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 112
Global 2024 Actual 91
Global 2023 Actual 17
Global 2022 Actual 6
Global 2021 Actual 7
Global 2020 Actual 2
China 2025 Actual 76
China 2024 Actual 51
China 2023 Actual 9
China 2022 Actual 3
China 2021 Actual 6
China 2020 Actual 1
United States 2025 Actual 21
United States 2024 Actual 27
United States 1 Jan 2023 to 27 Sep 2026 Actual 67
United States 2022 Actual 2
United States 2021 Actual 0
United States 2020 Actual 1
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0